ROCKWELL MEDICAL, INC. Debt Securities Available For Sale Excluding Accrued Interest
ROCKWELL MEDICAL, INC. (RMTI) had Debt Securities Available For Sale Excluding Accrued Interest of $14.28 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets
us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest · last filed 2026-08-13
- 2026-06-30: Debt Securities Available For Sale Excluding Accrued Interest $14.28M.
- 2026-03-31: Debt Securities Available For Sale Excluding Accrued Interest $14.28M.
- 2025-12-31: Debt Securities Available For Sale Excluding Accrued Interest $14.29M.
- 2025-09-30: Debt Securities Available For Sale Excluding Accrued Interest $10.10M.
| Period end | Debt Securities Available For Sale Excluding Accrued Interest |
|---|---|
| 2026-06-30 | $14.28M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $14.28M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $14.29M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $10.10M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $5.94M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $5.94M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $5.94M 10-Q · filed 2025-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |